These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 16216034)
1. Der(8)t(1;8) in myeloblastic transformation of ET with hydroxyurea as the sole prior treatment. Chim CS; Ma SK Hematol Oncol; 2005 Jun; 23(2):57-60. PubMed ID: 16216034 [TBL] [Abstract][Full Text] [Related]
2. Acute myeloid leukemia (AML) having evolved from essential thrombocythemia (ET): distinctive chromosome abnormalities in patients treated with pipobroman or hydroxyurea. Bernasconi P; Boni M; Cavigliano PM; Calatroni S; Brusamolino E; Passamonti F; Volpe G; Pistorio A; Giardini I; Rocca B; Caresana M; Lazzarino M; Bernasconi C Leukemia; 2002 Oct; 16(10):2078-83. PubMed ID: 12357360 [TBL] [Abstract][Full Text] [Related]
3. Molecular cytogenetic analysis of complex karyotypes with derivative chromosome der(1)t(1;5) found in two patients with myeloid leukemia. Melichercíková J; Brezinová J; Zemanová Z; Cermák J; Michalová K Cancer Genet Cytogenet; 2007 Jul; 176(2):150-5. PubMed ID: 17656259 [TBL] [Abstract][Full Text] [Related]
4. Translocation (3;8)(q26;q24): a recurrent chromosomal abnormality in myelodysplastic syndrome and acute myeloid leukemia. Lin P; Medeiros LJ; Yin CC; Abruzzo LV Cancer Genet Cytogenet; 2006 Apr; 166(1):82-5. PubMed ID: 16616115 [TBL] [Abstract][Full Text] [Related]
5. Is treatment with hydroxyurea leukemogenic in patients with essential thrombocythemia? An analysis of three new cases of leukaemic transformation and review of the literature. Liozon E; Brigaudeau C; Trimoreau F; Desangles F; Fermeaux V; Praloran V; Bordessoule D Hematol Cell Ther; 1997 Feb; 39(1):11-8. PubMed ID: 9088933 [TBL] [Abstract][Full Text] [Related]
6. Leukemic transformation of polycythemia vera after treatment with hydroxyurea with abnormalities of chromosome 17. Tóthová E; Fricová M; Stecová N; Hlebasková M; Kafková A; Raffac S; Guman T; Svorcová E; Nebesnáková E Neoplasma; 2001; 48(5):389-92. PubMed ID: 11845984 [TBL] [Abstract][Full Text] [Related]
7. Essential thrombocythemia and acute leukemia. Ferrari D; Ticozzelli G; De Vizzi M; Corigliano P; De Vizzi G Haematologica; 1993; 78(6):401-2. PubMed ID: 8175035 [TBL] [Abstract][Full Text] [Related]
8. Isolated myelosarcoma development in an adolescent chronic myeloid leukemia patient with t(9;22)(q34;q11.2), +8, +14, +21, and der(1)(p36). Oren H; Yilmaz S; Sercan Z; Demircioğlu F; Yüksel E; Irken G Cancer Genet Cytogenet; 2008 Apr; 182(1):43-5. PubMed ID: 18328950 [TBL] [Abstract][Full Text] [Related]
9. Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion. Sterkers Y; Preudhomme C; Laï JL; Demory JL; Caulier MT; Wattel E; Bordessoule D; Bauters F; Fenaux P Blood; 1998 Jan; 91(2):616-22. PubMed ID: 9427717 [TBL] [Abstract][Full Text] [Related]
10. [Essential thrombocythemia in transformation to acute leukemia (FAB-M0) as a natural history from myelofibrosis with t(1;7)]. Hayashi S; Iwama H; Uchida Y; Kawakubo K; Inatomi Y; Nagasu M; Miyazawa K; Ohyashiki JH; Ohyashiki K; Toyama K Rinsho Ketsueki; 1997 May; 38(5):445-7. PubMed ID: 9194391 [TBL] [Abstract][Full Text] [Related]
11. A case of chronic myeloproliferative syndrome followed by precursor T-cell acute lymphoblastic leukemia. Bacher U; Haferlach T; Kern W; Harich HD; Schnittger S; Haferlach C Cancer Genet Cytogenet; 2007 May; 175(1):52-6. PubMed ID: 17498558 [TBL] [Abstract][Full Text] [Related]
12. Childhood myeloid/natural killer precursor acute leukemia with novel chromosomal aberrations der(5)t(4;5)(q31;q31.3) and t(14;17)(q32;q23). Abdelhaleem M; Shago M; Sayeh E; Abla O Cancer Genet Cytogenet; 2007 Oct; 178(2):141-3. PubMed ID: 17954270 [TBL] [Abstract][Full Text] [Related]
13. A rare case of acute myeloid leukemia evolving from a myelodysplastic syndrome with der(19)t(1;19). Pinheiro RF; Chauffaille Mde L; Silva MR Cancer Genet Cytogenet; 2006 Sep; 169(2):181-3. PubMed ID: 16938581 [No Abstract] [Full Text] [Related]
14. Chronic myelomonocytic leukemia with der(9)t(1;9)(q11;q34) as a sole abnormality. Suh B; Park TS; Kim JS; Song J; Kim J; Yoo JH; Choi JR Ann Clin Lab Sci; 2009; 39(3):307-12. PubMed ID: 19667417 [TBL] [Abstract][Full Text] [Related]
15. [The value of multiplex fluorescence in situ hybridization in the detection of complex karyotypic abnormalities of acute myeloid leukemia]. Ma L; Li JY; Pan JL; Xiao B; Qian SX; Chen LJ; Qiu HR; Wen BZ; Xue YQ Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):318-22. PubMed ID: 16875581 [TBL] [Abstract][Full Text] [Related]
16. Molecular cytogenetic investigations in a novel complex variant of t(8;21)(q22;q22) with ins(15;21)(q15;q22.2q22.3) in a patient with AML-M2 subtype. Kokate P; Ahmad F; Dalvi R; Das BR; Mandava S Cancer Genet Cytogenet; 2008 Jul; 184(1):52-6. PubMed ID: 18558290 [TBL] [Abstract][Full Text] [Related]
17. Essential thrombocythemia terminating in pure erythroleukemia. Kreft A; Burg J; Fischer T; Kirkpatrick CJ Am J Hematol; 2004 Oct; 77(2):140-3. PubMed ID: 15389906 [TBL] [Abstract][Full Text] [Related]
18. Leukemogenic risk of hydroxyurea therapy as a single agent in polycythemia vera and essential thrombocythemia: N- and K-ras mutations and microsatellite instability in chromosomes 5 and 7 in 69 patients. Mavrogianni D; Viniou N; Michali E; Terpos E; Meletis J; Vaiopoulos G; Madzourani M; Pangalis G; Yataganas X; Loukopoulos D Int J Hematol; 2002 May; 75(4):394-400. PubMed ID: 12041671 [TBL] [Abstract][Full Text] [Related]
19. Benzene-induced acute myeloid leukemia: a clinician's perspective. Natelson EA Am J Hematol; 2007 Sep; 82(9):826-30. PubMed ID: 17506065 [TBL] [Abstract][Full Text] [Related]
20. Cytogenetic findings in untreated patients with essential thrombocythemia. Panani AD In Vivo; 2006; 20(3):381-4. PubMed ID: 16724675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]